Pharma & Healthcare Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

Global (United States, European Union and China) Fluticasone propionate Market Research Report 2019-2025

Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly affect the m...

$3,280.00 16 August, 2019 | QYResearch

Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly af...

Pharma & Healthcare

Global (United States, European Union and China) Iclusig Market Research Report 2019-2025

Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acut...

$3,280.00 16 August, 2019 | QYResearch

Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive ...

Pharma & Healthcare

Global (United States, European Union and China) Rivastigmine Oral Market Research Report 2019-2025

Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkin...

$3,280.00 16 August, 2019 | QYResearch

Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease ...

Pharma & Healthcare

Global (United States, European Union and China) Sartans Market Research Report 2019-2025

Sartans are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure)...

$3,280.00 16 August, 2019 | QYResearch

Sartans are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood...

Pharma & Healthcare

Global (United States, European Union and China) Venofer (iron sucrose injection) Market Research Report 2019-2025

Venofer® (iron sucrose injection, USP) provides first-line IV iron therapy for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients ...

$3,280.00 16 August, 2019 | QYResearch

Venofer® (iron sucrose injection, USP) provides first-line IV iron therapy for the treatment of iron deficiency anemia (IDA) in adult and pediatric...

Pharma & Healthcare

Global (United States, European Union and China) Clindamycin phosphate Topical Market Research Report 2019-2025

Clindamycin Phosphate Topical, USP 1% is indicated in the treatment of acne vulgaris. In 2019, the market size of Clindamycin phosphate Topical is xx million...

$3,280.00 16 August, 2019 | QYResearch

Clindamycin Phosphate Topical, USP 1% is indicated in the treatment of acne vulgaris. In 2019, the market size of Clindamycin phosphate Topical is ...

Pharma & Healthcare

Global (United States, European Union and China) Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Research Report 2019-2025

Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of ga...

$3,280.00 16 August, 2019 | QYResearch

Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a g...

Pharma & Healthcare

Global (United States, European Union and China) Sex Hormones Market Research Report 2019-2025

Sex Hormones is a type of Steroids, it is also called anabolic steroids, it include progesterone, testosterone etc. Sex Hormones mark a faster growth rate in...

$3,280.00 16 August, 2019 | QYResearch

Sex Hormones is a type of Steroids, it is also called anabolic steroids, it include progesterone, testosterone etc. Sex Hormones mark a faster grow...

Pharma & Healthcare

Global (United States, European Union and China) Alzheimer's Disease Therapeutics and Diagnostics Market Research Report 2019-2025

Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cas...

$3,280.00 16 August, 2019 | QYResearch

Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the num...

Pharma & Healthcare

Global (United States, European Union and China) Anti-Suicide Drugs Market Research Report 2019-2025

Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant...

$3,280.00 16 August, 2019 | QYResearch

Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-...